Older articles »
|Juno And Other Gene Therapy Players Are Hot Despite Ongoing Pricing Debates|
Added: 18.01.2018 16:04 | 0 views | 0 comments
The rumored acquisition of CAR-T developer Juno by Celgene has ignited investor enthusiasm for gene therapy. But in the background, concerns about how the healthcare system will afford these pricey new treatments persist.
|Researchers build immune systems for kids with 'Bubble Boy' disease|
Added: 15.01.2018 3:00 | 0 views | 0 comments
A new type of gene therapy pioneered at St. Jude Children's Research Hospital appears to build fully functional immune systems in babies.
|Non-Profit Says $850,000 Gene Therapy Is At Least Twice As Expensive As It Should Be|
Added: 12.01.2018 18:34 | 0 views | 0 comments
The non-profit Institute for Clinical Evaluation and Review (ICER) says that undisputed breakthrough should cost $400,000 at most, and perhaps $200,000. At that price, would it even exist?
|Diabetes: Can gene therapy normalize blood glucose levels?|
Added: 08.01.2018 8:00 | 3 views | 0 comments
Researchers from the University of Pittsburgh have shown that alpha cells can be reprogrammed into beta cells to restore blood glucose levels in diabetes.
|Gene therapy restores normal blood glucose levels in mice with type 1 diabetes|
Added: 06.01.2018 18:02 | 3 views | 0 comments
A study demonstrates that a gene therapy approach can lead to the long-term survival of functional beta cells as well as normal blood glucose levels for an extended period of time in mice with type 1 diabetes. The researchers used an adeno-associated viral (AAV) vector to deliver to the mouse pancreas two proteins, Pdx1 and MafA, which reprogrammed plentiful alpha cells into functional, insulin-producing beta cells.
|When the Lung Cancer Patient Climbs Mountains|
Added: 04.01.2018 13:04 | 6 views | 0 comments
A gene therapy clinical trial enabled a Stage IV lung cancer patient to summit a peak in the Himalayas.
|Gene therapy for rare blindness: $US850K|
Added: 04.01.2018 2:28 | 1 views | 0 comments
A first-of-its kind genetic treatment for blindness will cost $US850,000 ($A1.2 million) per patient, making it one of the most expensive medicines in the world and raising questions about the affordability of a coming wave of similar gene-targeting therapies.
|Gene therapy for blindness to cost $850,000|
Added: 03.01.2018 21:13 | 2 views | 0 comments
A new gene therapy called Luxturna, approved to treat progressive blindness, will cost $850,000, says Spark Therapeutics, the company that makes it.
Copyright © 2008-2018 gffnews.com - all rights reserved